Minimed Group, Inc. (MMED)

NASDAQ: MMED · Real-Time Price · USD
14.01
-0.47 (-3.25%)
At close: Apr 2, 2026, 4:00 PM EDT
14.06
+0.05 (0.36%)
After-hours: Apr 2, 2026, 7:43 PM EDT
Market Cap3.93B
Revenue (ttm)2.89B +28.6%
Net Income-211.00M
EPSn/a
Shares Out 280.81M
PE Ration/a
Forward PE37.34
Dividendn/a
Ex-Dividend Daten/a
Volume724,636
Open14.27
Previous Close14.48
Day's Range13.52 - 14.97
52-Week Range13.52 - 20.48
Betan/a
AnalystsStrong Buy
Price Target22.56 (+61.03%)
Earnings DateMay 10, 2026

About MMED

Minimed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin therapy, which represents all people with T1D and a subset of those with T2D. The company’s platform includes Automated Insulin Delivery (AID) systems f... [Read more]

Sector Healthcare
IPO Date Mar 6, 2026
Employees 8,000
Stock Exchange NASDAQ
Ticker Symbol MMED
Full Company Profile

Financial Performance

In fiscal year 2025, Minimed Group's revenue was $2.72 billion, an increase of 9.96% compared to the previous year's $2.47 billion. Losses were -$213.00 million, 90.2% more than in 2024.

Financial Statements

Analyst Summary

According to 10 analysts, the average rating for MMED stock is "Strong Buy." The 12-month stock price target is $22.56, which is an increase of 61.03% from the latest price.

Price Target
$22.56
(61.03% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

MiniMed Announces FDA Clearance of MiniMed Flex™, the Company's Smallest Insulin Pump Featuring Its First Smartphone-Controlled Design

MiniMed Flex™ is about half the size of the previous generation MiniMed™ 780G system, and features the SmartGuard™ adaptive algorithm to automatically adjust and autocorrect insulin delivery in real-t...

18 days ago - PRNewsWire

MiniMed announces closing of Initial Public Offering

NORTHRIDGE, Calif., March 9, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED) today announced the closing of its previously announced initial public offering (IPO) of 28,000,000 shares...

27 days ago - PRNewsWire

Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut

Shares of MiniMed , the ​diabetes business of medical device ‌maker Medtronic , opened 4.8% below their offer price in their Nasdaq ​debut on Friday, valuing ​it at $5.3 billion.

Other symbols: MDT
4 weeks ago - Reuters

MiniMed to begin trading on Nasdaq Global Select Market

GALWAY, Ireland, March 6, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced that MiniMed Group, Inc. (Nasdaq: MMED) will begin trading today on the Na...

Other symbols: MDT
4 weeks ago - PRNewsWire

MiniMed begins trading on Nasdaq Global Select Market

NORTHRIDGE, Calif., March 6, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed; Nasdaq: MMED), a global leader in diabetes management, will begin trading on the Nasdaq Global Select Market (Nasdaq) to...

4 weeks ago - PRNewsWire

Medtronic's diabetes unit MiniMed raises $560 million in US IPO

MiniMed, the ​diabetes business ‌of medical ​device ​maker Medtronic , said ⁠on ​Thursday it ​has raised $560 million ​in ​its U.S. initial ‌public ⁠offering.

Other symbols: MDT
4 weeks ago - Reuters

Medtronic's MiniMed aims to raise $784 million in US IPO

Medtronic's diabetes business MiniMed Group said on Tuesday it was aiming to raise as much as $784 million in its initial public offering in the United States.

Other symbols: MDT
5 weeks ago - Reuters

Study showed MiniMed™ 780G system achieved ADA-recommended time-in-range goals even on days users forgot to bolus

GALWAY, Ireland, Jan. 7, 2026 /PRNewswire/ -- A new real-world retrospective analysis published in Diabetes Care  showed that users of the MiniMed™ 780G system achieved American Diabetes Association (...

3 months ago - PRNewsWire

Medtronic Spin-Off MiniMed Files for IPO

Medtronic will own at least 80.1% of the voting stock for MiniMed once the IPO is complete.

Other symbols: MDT
3 months ago - WSJ

Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed

GALWAY, Ireland , Dec. 19, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will oper...

Other symbols: MDT
3 months ago - PRNewsWire

Medtronic's MiniMed files for US IPO

MiniMed Group, the diabetes business of medical device maker Medtronic , filed for an initial public offering in the United States on Friday.

Other symbols: MDT
3 months ago - Reuters

MiniMed Group IPO Registration Document (S-1)

MiniMed Group has filed to go public with an IPO on the NASDAQ.

3 months ago - SEC